Henoch-Schönlein purpura and meningococcal B vaccination.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 18650242.
- Also identified by DOI 10.1136/adc.2007.125195.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The risk of Henoch-Schönlein purpura (HSP) following vaccination with a group B meningococcal vaccine was assessed through active hospital safety monitoring. There was no increase in the relative incidence of HSP within 30 days after vaccination nor recurrence in HSP cases who received one or more further vaccine doses (re-challenge).
Medical subject headings
- Drug Eruptions
- IgA Vasculitis
- Meningococcal Vaccines